XILICA CAP
XILICA CAP (Pregabalin 25mg/50mg/75mg/100mg/150mg)
Take A Step from Unpleasant to Pleasant
- AAN & EFNS recommend pregabalin as a 1st line treatment for neuropathic
- A Pronounced shift in neuropathic pain burden
- Effectiv3e for treating chronic low back pain
- Well tolerated amongst patients
INDICATIONS
XILICA (Pregabalin) is indicated for
• Management of neuropathic pain associated with diabetic peripheral neuropathy
• Management of post herpetic neuralgia
• Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
• Management of fibromyalgia
• Management of neuropathic pain associated with spinal cord injury.